Healthequity Inc (NASDAQ:HQY) – Stock analysts at Cantor Fitzgerald decreased their FY2018 earnings per share estimates for shares of Healthequity in a research note issued to investors on Wednesday. Cantor Fitzgerald analyst S. Halper now expects that the company will post earnings per share of $0.65 for the year, down from their prior forecast of $0.67. Cantor Fitzgerald currently has a “Buy” rating and a $56.00 target price on the stock.

Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.04. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The business had revenue of $56.80 million for the quarter, compared to analysts’ expectations of $55.27 million. During the same period last year, the business earned $0.10 EPS. The company’s revenue was up 31.0% compared to the same quarter last year.

Other analysts have also recently issued reports about the stock. Zacks Investment Research upgraded shares of Healthequity from a “hold” rating to a “buy” rating and set a $60.00 price target on the stock in a report on Wednesday, November 8th. Oppenheimer restated a “buy” rating and issued a $61.00 price target on shares of Healthequity in a report on Wednesday, September 6th. Chardan Capital raised their price target on shares of Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a report on Wednesday, December 6th. BidaskClub upgraded shares of Healthequity from a “sell” rating to a “hold” rating in a report on Thursday, September 28th. Finally, Robert W. Baird reaffirmed a “hold” rating on shares of Healthequity in a research report on Thursday, September 21st. One analyst has rated the stock with a sell rating, two have given a hold rating and eight have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $58.33.

Shares of Healthequity (NASDAQ HQY) opened at $45.72 on Monday. Healthequity has a 1-year low of $37.62 and a 1-year high of $55.31. The firm has a market cap of $2,773.95, a PE ratio of 65.31, a PEG ratio of 1.98 and a beta of 1.74.

Institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. increased its holdings in shares of Healthequity by 3.0% during the 2nd quarter. Vanguard Group Inc. now owns 4,237,298 shares of the company’s stock valued at $211,145,000 after purchasing an additional 122,061 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Healthequity by 25.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 473,433 shares of the company’s stock valued at $23,591,000 after purchasing an additional 95,514 shares in the last quarter. First Trust Advisors LP increased its holdings in shares of Healthequity by 17.0% during the 2nd quarter. First Trust Advisors LP now owns 94,283 shares of the company’s stock valued at $4,698,000 after purchasing an additional 13,676 shares in the last quarter. Fred Alger Management Inc. increased its holdings in shares of Healthequity by 30.4% during the 2nd quarter. Fred Alger Management Inc. now owns 265,369 shares of the company’s stock valued at $13,223,000 after purchasing an additional 61,880 shares in the last quarter. Finally, Legal & General Group Plc increased its holdings in shares of Healthequity by 12.7% during the 2nd quarter. Legal & General Group Plc now owns 87,541 shares of the company’s stock valued at $4,360,000 after purchasing an additional 9,858 shares in the last quarter. 98.60% of the stock is owned by institutional investors.

In other Healthequity news, Director Frank Medici sold 316,644 shares of the firm’s stock in a transaction that occurred on Monday, October 9th. The shares were sold at an average price of $51.96, for a total transaction of $16,452,822.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Stephen Neeleman sold 8,500 shares of the firm’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $45.24, for a total transaction of $384,540.00. Following the transaction, the insider now directly owns 1,000 shares of the company’s stock, valued at $45,240. The disclosure for this sale can be found here. Insiders sold a total of 1,743,212 shares of company stock valued at $91,145,351 over the last ninety days. 19.00% of the stock is currently owned by insiders.

TRADEMARK VIOLATION WARNING: “Cantor Fitzgerald Analysts Reduce Earnings Estimates for Healthequity Inc (HQY)” was originally posted by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://www.dailypolitical.com/2017/12/11/cantor-fitzgerald-analysts-reduce-earnings-estimates-for-healthequity-inc-hqy.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity Inc and related companies with MarketBeat.com's FREE daily email newsletter.